UNSPSC 51332706: Clocapramine hydrochloride

This classification denotes an antidepressant agent with the molecular structure C28H37CLN4O.2CLH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9NLU6H3LRD chemically known as 1'-(3-(3-chloro-10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)(1,4'-bipiperidine)-4'-carboxamide dihydrochloride monohydrate, but more commonly known as clocapramine hydrochloride, which bears US NIH Compound Identifier 5282503.

European Medicines Agency schedules Clocapramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01349MIG. Most nations, for tariff and trade purposes, schedule clocapramine hydrochloride under HS 29333999 and SITC 51574. SMILES: C1CCC2C(C1)CCC3CCC(CC3N2CCCN4CCC(CC4)(C(=O)N)N5CCCCC5)CL.O.CL.CL.

UNSPSC 51332706 Clocapramine hydrochloride is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities—a Seminole County naloxone and drug deactivation systems purchase, a Texas HHS direct-to-manufacturer prescription program RFI, and a Minnesota multistate cooperative generic pharmaceuticals and OTC products RFP—involve naloxone, broad-based pharmaceutical distribution channels, and generic multi-source drugs rather than the specific pharmaceutical clocapramine hydrochloride. The code shows little relevant recent activity; state and local procurement systems appear to be applying the code to pharmaceutical supply and distribution broadly rather than to this particular active pharmaceutical ingredient or formulation.

No recent opportunities specifically soliciting clocapramine hydrochloride or products containing it have been posted by state and local jurisdictions.